homocysteine has been researched along with transforming growth factor beta in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 8 (57.14) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Assmann, G; Breithardt, G; Cullen, P; Erren, M; Fobker, M; Junker, R; Kerber, S; Kropf, J; Reinecke, H; Schulte, H; Schurek, JO | 1 |
Hashimoto, S; Midorikawa, S; Sanada, H; Watanabe, T | 1 |
Bølling, S; Djurovic, S; Os, A; Os, I; Sandset, PM; Seljeflot, I; Westheim, A | 1 |
Bohle, B; Födinger, M; Hörl, WH; Kletzmayr, J; Papagiannopoulos, M; Sengoelge, G; Sunder-Plassmann, G | 1 |
Carroll, JF; Tyagi, SC | 1 |
Bourdon, E; Delabar, JM; Delcayre, C; Friguet, B; Janel, N; Nehmé, J; Pivert, G; Robert, K | 1 |
Altun, B; Arici, M; Bakkaloğlu, M; Gençtoy, G; Hayran, M; Kahraman, S; Onalan, O; Oto, A; Turgan, C; Yasavul, U; Yilmaz, R | 1 |
Blakytny, R; Brunner, G; Erkell, LJ | 1 |
Ferrannini, E; Nannipieri, M; Santini, E; Solini, A | 1 |
Day, EC; Shlipak, MG | 1 |
Gao, W; Guo, RC; Jia, Q; Liang, ES; Lin, WW; Liu, DS; Wang, SL; Zhang, JD; Zhang, WD | 1 |
da Guarda, CC; Dias Zanette, AM; Figueiredo, CV; Goncalves, Mde S; Pitanga, TN; Santana, SS; Santiago, RP; Veloso Cerqueira, BA; Vilas-Boas, W | 1 |
Geng, J; Li, X; Wang, L; Zhang, Y; Zhou, X | 1 |
Bu, S; Chu, Y; Dai, H; Hu, F; Hu, P; Qiu, X; Sha, W; Yang, X | 1 |
1 review(s) available for homocysteine and transforming growth factor beta
Article | Year |
---|---|
Biomarkers for incident CKD: a new framework for interpreting the literature.
Topics: Acute-Phase Proteins; Aldosterone; Biomarkers; Connective Tissue Growth Factor; Creatinine; Cystatin C; Genetic Markers; Genetic Predisposition to Disease; Glomerular Filtration Rate; Hepatitis A Virus Cellular Receptor 1; Homocysteine; Humans; Lipocalin-2; Lipocalins; Membrane Glycoproteins; Peptides; Proto-Oncogene Proteins; Receptors, Virus; Renal Insufficiency, Chronic; Risk Factors; Transforming Growth Factor beta; Trefoil Factor-3; Uromodulin | 2013 |
2 trial(s) available for homocysteine and transforming growth factor beta
Article | Year |
---|---|
Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
Topics: Administration, Cutaneous; Age Factors; Aged; Biomarkers; Body Mass Index; C-Peptide; Coronary Artery Disease; E-Selectin; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Severity of Illness Index; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Women's Health | 2002 |
Association of homocysteine and inflammatory-related molecules in sickle cell anemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Animals; Child; Female; Homocysteine; Humans; Inflammation Mediators; Interleukin-17; Male; Mice; Transforming Growth Factor beta; Vascular Cell Adhesion Molecule-1 | 2016 |
11 other study(ies) available for homocysteine and transforming growth factor beta
Article | Year |
---|---|
Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries.
Topics: Acute-Phase Reaction; Adult; Aged; Arteritis; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Constriction, Pathologic; Coronary Artery Disease; Female; Fibrinogen; Homocysteine; Humans; Interleukin-6; Intermittent Claudication; Logistic Models; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Popliteal Artery; Risk Assessment; Transforming Growth Factor beta; Triglycerides | 1999 |
Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells.
Topics: Arteriosclerosis; Cells, Cultured; Endothelium, Vascular; Gene Expression; Homocysteine; Humans; Hyperhomocysteinemia; Muscle, Smooth, Vascular; Plasminogen Activator Inhibitor 1; RNA, Messenger; Thrombosis; Tissue Plasminogen Activator; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2000 |
TGF-beta1 impairs homocysteine metabolism in human renal cells: possible implications for transplantation.
Topics: Cells, Cultured; Epithelial Cells; Homocysteine; Humans; Hyperhomocysteinemia; Interleukin-1; Interleukin-10; Kidney Transplantation; Kidney Tubules, Proximal; Predictive Value of Tests; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit.
Topics: Animals; Collagen; Coronary Vessels; Extracellular Matrix; Female; Homocysteine; Hypertrophy; Multiple Organ Failure; Myocardium; Obesity; Rabbits; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver.
Topics: Animals; Apoptosis; Collagen Type I; Cystathionine beta-Synthase; Disease Models, Animal; Fatty Liver; Homocysteine; Homocystinuria; Hyperhomocysteinemia; Liver; Liver Cirrhosis; Mice; Mice, Mutant Strains; Oxidative Stress; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
Topics: Adult; Cardiovascular Diseases; Carotid Arteries; Cytokines; Female; Genotype; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Transplantation; Lipoprotein(a); Male; Middle Aged; Polymorphism, Genetic; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Tunica Intima | 2005 |
Inactivation of active and latent transforming growth factor beta by free thiols: potential redox regulation of biological action.
Topics: Bacitracin; Blotting, Western; Cysteine; Dimerization; Dithiothreitol; Dose-Response Relationship, Drug; Glutathione; Homocysteine; Humans; Oxidation-Reduction; Recombinant Proteins; Sulfhydryl Compounds; Temperature; Transforming Growth Factor beta | 2006 |
High glucose and homocysteine synergistically affect the metalloproteinases-tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts.
Topics: Drug Synergism; Fibroblasts; Glucose; Homocysteine; Humans; Hyperhomocysteinemia; Metalloproteases; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta | 2006 |
Effects of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunction.
Topics: Animals; Aorta; Disulfides; Endothelins; Endothelium, Vascular; Fibroblast Growth Factor 2; Gene Expression Regulation; Homocysteine; Hyperhomocysteinemia; Intercellular Adhesion Molecule-1; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Wistar; Sulfinic Acids; Superoxide Dismutase; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2013 |
The immunomodulatory mechanism of brain injury induced by hyperhomocysteinemia in spontaneously hypertensive rats.
Topics: Animals; Blood-Brain Barrier; Brain Injuries; Forkhead Transcription Factors; Homocysteine; Humans; Hyperhomocysteinemia; Immunomodulation; Inflammation; Interleukin-10; Interleukin-17; Interleukin-6; Methionine; Nuclear Receptor Subfamily 1, Group F, Member 3; Rats; Rats, Inbred SHR; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Transforming Growth Factor beta | 2019 |
Lower expression of Hsa_circRNA_102682 in diabetic hyperhomocysteinemia negatively related to creatinemia is associated with TGF-β and CTGF.
Topics: Connective Tissue Growth Factor; Creatinine; Diabetic Nephropathies; Gene Expression Regulation; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; RNA, Circular; ROC Curve; Transforming Growth Factor beta | 2021 |